Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury

NCT03995732 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Reperfusion Injury

Interventions

DRUG: PC-SOD
DRUG: placebo

Sponsor

Beijing Tide Pharmaceutical Co., Ltd

Collaborators

[object Object]